Annual EBIT
-$15.98 M
-$3.39 M-26.93%
December 31, 2023
Summary
- As of February 8, 2025, KTTA annual earnings before interest & taxes is -$15.98 million, with the most recent change of -$3.39 million (-26.93%) on December 31, 2023.
- KTTA annual EBIT is now -635.36% below its all-time high of -$2.17 million, reached on December 31, 2021.
Performance
KTTA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$3.00 M
+$940.40 K+23.84%
September 30, 2024
Summary
- As of February 8, 2025, KTTA quarterly earnings before interest & taxes is -$3.00 million, with the most recent change of +$940.40 thousand (+23.84%) on September 30, 2024.
- Over the past year, KTTA quarterly EBIT has increased by +$940.40 thousand (+23.84%).
- KTTA quarterly EBIT is now -894.66% below its all-time high of $378.10 thousand, reached on December 31, 2021.
Performance
KTTA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$16.14 M
+$784.70 K+4.64%
September 30, 2024
Summary
- As of February 8, 2025, KTTA TTM earnings before interest & taxes is -$16.14 million, with the most recent change of +$784.70 thousand (+4.64%) on September 30, 2024.
- Over the past year, KTTA TTM EBIT has increased by +$784.70 thousand (+4.64%).
- KTTA TTM EBIT is now -115180.00% below its all-time high of -$14.00 thousand, reached on September 30, 2020.
Performance
KTTA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
KTTA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -26.9% | +23.8% | +4.6% |
| 3 y3 years | - | +22.1% | -118.6% |
| 5 y5 years | - | +22.1% | -118.6% |
KTTA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -635.4% | at low | -894.7% | +41.6% | -642.7% | +4.6% |
| 5 y | 5-year | -635.4% | at low | -894.7% | +41.6% | <-9999.0% | +4.6% |
| alltime | all time | -635.4% | at low | -894.7% | +41.6% | <-9999.0% | +4.6% |
Pasithea Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.00 M(-23.8%) | -$16.14 M(-4.6%) |
| Jun 2024 | - | -$3.94 M(-2.4%) | -$16.92 M(+0.7%) |
| Mar 2024 | - | -$4.04 M(-21.5%) | -$16.81 M(+4.9%) |
| Dec 2023 | -$15.98 M(+26.9%) | -$5.15 M(+35.9%) | -$16.03 M(+7.4%) |
| Sep 2023 | - | -$3.79 M(-1.0%) | -$14.92 M(-0.4%) |
| Jun 2023 | - | -$3.83 M(+17.5%) | -$14.99 M(+8.8%) |
| Mar 2023 | - | -$3.26 M(-19.4%) | -$13.77 M(+16.7%) |
| Dec 2022 | -$12.59 M | -$4.04 M(+4.9%) | -$11.80 M(+59.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$3.86 M(+47.6%) | -$7.38 M(+53.8%) |
| Jun 2022 | - | -$2.61 M(+101.9%) | -$4.80 M(+64.6%) |
| Mar 2022 | - | -$1.29 M(-442.1%) | -$2.92 M(+34.2%) |
| Dec 2021 | -$2.17 M | $378.10 K(-129.7%) | -$2.17 M(-14.8%) |
| Sep 2021 | - | -$1.27 M(+75.0%) | -$2.55 M(+97.5%) |
| Jun 2021 | - | -$727.90 K(+32.4%) | -$1.29 M(+129.2%) |
| Mar 2021 | - | -$549.60 K(+3825.7%) | -$563.60 K(+3925.7%) |
| Sep 2020 | - | -$14.00 K | -$14.00 K |
FAQ
- What is Pasithea Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Pasithea Therapeutics?
- What is Pasithea Therapeutics annual EBIT year-on-year change?
- What is Pasithea Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Pasithea Therapeutics?
- What is Pasithea Therapeutics quarterly EBIT year-on-year change?
- What is Pasithea Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Pasithea Therapeutics?
- What is Pasithea Therapeutics TTM EBIT year-on-year change?
What is Pasithea Therapeutics annual earnings before interest & taxes?
The current annual EBIT of KTTA is -$15.98 M
What is the all time high annual EBIT for Pasithea Therapeutics?
Pasithea Therapeutics all-time high annual earnings before interest & taxes is -$2.17 M
What is Pasithea Therapeutics annual EBIT year-on-year change?
Over the past year, KTTA annual earnings before interest & taxes has changed by -$3.39 M (-26.93%)
What is Pasithea Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of KTTA is -$3.00 M
What is the all time high quarterly EBIT for Pasithea Therapeutics?
Pasithea Therapeutics all-time high quarterly earnings before interest & taxes is $378.10 K
What is Pasithea Therapeutics quarterly EBIT year-on-year change?
Over the past year, KTTA quarterly earnings before interest & taxes has changed by +$940.40 K (+23.84%)
What is Pasithea Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of KTTA is -$16.14 M
What is the all time high TTM EBIT for Pasithea Therapeutics?
Pasithea Therapeutics all-time high TTM earnings before interest & taxes is -$14.00 K
What is Pasithea Therapeutics TTM EBIT year-on-year change?
Over the past year, KTTA TTM earnings before interest & taxes has changed by +$784.70 K (+4.64%)